Abbvie Piotroski F Score

ABBV
 Stock
  

USD 138.04  0.88  0.63%   

This module uses fundamental data of Abbvie to approximate its Piotroski F score. Abbvie F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Abbvie Inc. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Abbvie financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Please continue to Abbvie Altman Z Score, Abbvie Correlation, Abbvie Valuation, as well as analyze Abbvie Alpha and Beta and Abbvie Hype Analysis.
  
Abbvie Debt Current is fairly stable at the moment as compared to the past year. Abbvie reported Debt Current of 12.49 Billion in 2021. Long Term Debt to Equity is likely to climb to 4.56 in 2022, whereas Total Debt is likely to drop slightly above 62.5 B in 2022. Abbvie Quick Ratio is fairly stable at the moment as compared to the past year. Abbvie reported Quick Ratio of 0.56 in 2021. Asset Turnover is likely to climb to 0.43 in 2022, whereas Receivables Turnover is likely to drop 5.49 in 2022.
At this time, it appears that Abbvie's Piotroski F Score is Strong. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
7.0
Piotroski F Score - Strong
1
Current Return On AssetsPositiveFocus
2
Change in Return on AssetsIncreasedFocus
3
Cash Flow Return on AssetsPositiveFocus
4
Current Quality of Earnings (accrual)ImprovingFocus
5
Asset Turnover GrowthIncreaseFocus
6
Current Ratio ChangeIncreaseFocus
7
Long Term Debt Over Assets ChangeLower LeverageFocus
8
Change In Outstending SharesIncreaseFocus
9
Change in Gross MarginNo ChangeFocus

Abbvie Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Abbvie is to make sure Abbvie is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Abbvie's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Abbvie's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares1.9 B1.8 B
Sufficiently Up
Increasing
Slightly volatile
Weighted Average Shares Diluted1.9 B1.8 B
Sufficiently Up
Increasing
Slightly volatile
Net Cash Flow from Operations18 B22.8 B
Significantly Down
Increasing
Slightly volatile
Total Assets116 B146.5 B
Significantly Down
Increasing
Slightly volatile
Total Liabilities105.4 B131.1 B
Significantly Down
Increasing
Slightly volatile
Current Assets26.7 B27.9 B
Sufficiently Down
Increasing
Slightly volatile
Current Liabilities38 B35.2 B
Significantly Up
Increasing
Slightly volatile
Total Debt62.5 B76.7 B
Significantly Down
Increasing
Slightly volatile
Return on Average Assets0.08740.078
Moderately Up
Decreasing
Slightly volatile
Gross Margin0.680.69
Fairly Down
Decreasing
Slightly volatile
Asset Turnover0.430.379
Moderately Up
Decreasing
Slightly volatile

Abbvie Inc F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Abbvie's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Abbvie in a much-optimized way.

About Abbvie Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value per Share

9.39

Abbvie Book Value per Share is fairly stable at the moment as compared to the past year. Abbvie reported Book Value per Share of 8.71 in 2021

Abbvie Current Valuation Drivers

We derive many important indicators used in calculating different scores of Abbvie from analyzing Abbvie's financial statements. These drivers represent accounts that assess Abbvie's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Abbvie's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee183.07 K189.57 K262.73 K97.94 K230.84 K195.69 K
Revenue Per Employee972.97 K1.09 M1.11 M971.89 K1.12 M970.16 K
Average Assets68.07 B64.12 B65.62 B135.23 B148.47 B160.19 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA10.23 B8.11 B11.95 B12.14 B23.89 B25.77 B
Earnings Before Interest Taxes and Depreciation Amortization USD10.23 B8.11 B11.95 B12.14 B23.89 B25.77 B
Earnings before Tax7.73 B5.2 B8.43 B3.39 B12.98 B10.48 B
Average Equity5.7 B(2.8 B)(8.2 B)8.91 B13.81 B14.9 B
Enterprise Value183.74 B171.17 B158.69 B268.34 B307.91 B261.19 B
Free Cash Flow9.43 B12.79 B12.77 B16.79 B21.99 B23.73 B
Invested Capital38.87 B38.24 B66.08 B83.51 B69.94 B59.64 B
Invested Capital Average41.72 B38 B44.01 B81.18 B77.72 B62.54 B
Market Capitalization154.39 B138.67 B130.93 B189.17 B239.37 B205.71 B
Tangible Asset Value27.44 B22.46 B54.86 B34.56 B38.2 B35.35 B
Working Capital4.58 B(294 M)33.93 B(4.49 B)(7.27 B)(7.46 B)

Abbvie ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbvie's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbvie's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

About Abbvie Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abbvie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbvie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbvie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbvie without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Pair Trading with Abbvie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbvie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbvie will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Abbvie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbvie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbvie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbvie Inc to buy it.
The correlation of Abbvie is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbvie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbvie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbvie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Abbvie Altman Z Score, Abbvie Correlation, Abbvie Valuation, as well as analyze Abbvie Alpha and Beta and Abbvie Hype Analysis. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.22
Market Capitalization
244.1 B
Quarterly Revenue Growth YOY
0.045
Return On Assets
0.0863
Return On Equity
0.83
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.